Skip to main content

Table 1 Frequency, age specific incidence rates, average annual crude incidence rates and ASR by site in females in Kumasi, 2015

From: Malignant tumours in urban Ghana: evidence from the city of Kumasi

Site/Age group

All Ages

Age unkwnon

0

5

10

15–19

20–24

25–29

30–34

35–39

40–44

45–49

50–54

55–59

60–64

65–69

70–74

75+

Crude Rate

%

Cum (0–64)

CUM (0–74)

ASR

ICD

Lip

1

0

3.6

0.1

0.2

0.00

0.00

0.1

C00

Tongue

0

0

0.0

0.0

0.00

0.00

0.0

C01–02

Mouth

2

0

1.7

3.9

0.2

0.4

0.03

0.03

0.3

C03–06

Salivary glands

2

0

2.4

6.9

0.2

0.4

0.01

0.05

0.3

C07–08

Tonsil

1

0

2.2

0.1

0.2

0.01

0.01

0.1

C09

Other oropharynx

0

0

0.0

0.0

0.00

0.00

0.0

C10

Nasopharynx

2

0

0.7

1.7

0.2

0.4

0.01

0.01

0.2

C11

Hypopharynx

0

0

0.0

0.0

0.00

0.00

0.0

C12–13

Pharynx unspecified

0

0

0.0

0.0

0.00

0.00

0.0

C14

Oesophagus

0

0

0.0

0.0

0.00

0.00

0.0

C15

Stomach

14

0

4.4

2.4

27.6

20.7

3.6

1.1

2.8

0.04

0.30

1.8

C16

Small intestine

0

0

0.0

0.0

0.00

0.00

0.0

C17

Colon

8

0

1.4

3.4

8.3

13.8

5.2

0.7

1.8

0.07

0.16

1.1

C18

Rectum

4

0

1.4

2.2

4.1

3.6

0.3

0.9

0.04

0.04

0.5

C19–20

Anus

5

0

4.7

3.9

7.2

0.4

1.1

0.04

0.04

0.5

C21

Liver

28

0

0.7

1.7

2.8

2.4

4.2

3.4

2.2

4.7

11.8

4.1

27.6

15.5

3.6

2.3

6.1

0.19

0.41

3.2

C22

Gallbladder etc.

0

0

0.0

0.0

0.00

0.00

0.0

C23–24

Pancreas

3

0

2.4

3.9

4.1

0.2

0.7

0.05

0.05

0.4

C25

Nose, sinuses etc.

1

0

0.7

0.1

0.2

0.00

0.00

0.1

C30–31

Larynx

1

0

4.1

0.1

0.2

0.02

0.02

0.2

C32

Trachea, bronchus and lung

5

0

0.9

8.3

7.2

0.4

1.1

0.05

0.05

0.5

C33–34

Other thoracic organs

0

0

0.0

0.0

0.00

0.00

0.0

C37–38

Bone

4

0

1.9

1.4

4.1

0.3

0.9

0.04

0.04

0.4

C40–41

Melanoma of skin

1

0

3.6

0.1

0.2

0.00

0.00

0.1

C43

Other skin

2

0

1.7

6.9

0.2

0.4

0.01

0.04

0.3

C44

Mesothelioma

0

0

0.0

0.0

0.00

0.00

0.0

C45

Kaposi sarcoma

1

0

2.4

0.1

0.2

0.01

0.01

0.1

C46

Connective and soft tissue

6

0

0.7

1.6

2.2

3.9

4.1

0.5

1.3

0.06

0.06

0.7

C47,C49

Breast

138

0

2.6

1.9

9.5

14.0

30.4

50.1

56.8

63.1

41.4

34.5

20.7

46.8

11.3

30.0

1.36

1.64

16.1

C50

Vulva

3

0

3.9

4.1

3.6

0.2

0.7

0.04

0.04

0.4

C51

Vagina

0

0

0.0

0.0

0.00

0.00

0.0

C52

Cervix uteri

107

0

0.9

2.4

7.0

16.9

30.5

23.7

63.1

58.0

75.9

31.1

4.8

8.9

23.4

1.01

1.55

13.7

C53

Corpus uteri

10

0

1.2

7.9

8.3

13.8

15.5

0.8

2.2

0.09

0.23

1.4

C54

Uterus unspecified

4

0

7.1

3.9

0.3

0.9

0.06

0.06

0.5

C55

Ovary

29

0

0.9

1.9

4.7

1.4

5.1

4.4

11.8

7.9

27.6

5.2

4.4

2.4

6.3

0.19

0.35

3.3

C56

Other female genital organs

0

0

0.0

0.0

0.00

0.00

0.0

C57

Placenta

5

0

1.7

0.9

1.2

1.7

0.4

1.1

0.03

0.03

0.4

C58

Kidney

4

0

0.6

0.8

0.9

2.4

0.3

0.9

0.02

0.02

0.3

C64

Renal pelvis

0

0

0.0

0.0

0.00

0.00

0.0

C65

Ureter

0

0

0.0

0.0

0.00

0.00

0.0

C66

Bladder

11

0

1.7

4.7

7.9

4.1

6.9

5.2

0.8

0.9

2.4

0.09

0.15

1.3

C67

Other urinary organs

0

0

0.0

0.0

0.00

0.00

0.0

C68

Eye

3

0

1.9

0.2

0.7

0.01

0.01

0.2

C69

Brain, nervous system

7

0

0.7

0.8

0.9

4.2

1.7

0.6

1.5

0.04

0.04

0.6

C70–72

Thyroid

3

0

3.9

4.1

5.2

0.2

0.7

0.04

0.07

0.4

C73

Adrenal gland

0

0

0.0

0.0

0.00

0.00

0.0

C74

Other endocrine

0

0

0.0

0.0

0.00

0.00

0.0

C75

Hodgkin disease

4

0

0.7

0.9

2.2

3.6

0.3

0.9

0.02

0.02

0.3

C81

Non-Hodgkin lymphoma

21

0

0.6

0.7

0.7

1.6

0.9

1.2

2.8

6.8

2.2

4.7

8.3

10.8

1.7

4.6

0.15

0.15

2.0

C82–85,C96

Immunoproliferative diseases

0

0

0.0

0.0

0.00

0.00

0.0

C88

Multiple myeloma

3

0

3.9

10.4

0.2

0.7

0.02

0.07

0.4

C90

Lymphoid leukaemia

3

0

0.6

0.7

0.9

0.2

0.7

0.01

0.01

0.2

C91

Myeloid leukaemia

7

0

1.2

0.7

3.4

7.9

0.6

1.5

0.07

0.07

0.7

C92–94

Leukaemia unspecified

0

0

0.0

0.0

0.00

0.00

0.0

C95

Myeloproliferative disorders

0

0

0.0

0.0

0.00

0.00

0.0

MPD

Myelodysplastic syndromes

0

0

0.0

0.0

0.00

0.00

0.0

MDS

Other and unspecified

8

0

0.8

1.9

2.2

4.7

4.1

3.6

0.7

1.8

0.07

0.07

0.8

O&U

All sites

459

0

5.0

2.0

5.1

5.6

8.5

16.0

22.5

37.9

79.5

104.6

134.9

201.2

174.0

241.6

134.6

90.9

38.0

 

4.00

5.89

54.1

ALL

All sites but C44

457

0

5.0

2.0

5.1

5.6

8.5

16.0

22.5

37.9

77.8

104.6

134.9

201.2

174.0

234.7

134.6

190.9

37.9

100.0

3.99

5.85

53.8

ALLbC44

  1. Reference population: world standard PopulationTable builtTue Apr 18 17:19:48 UTC 2017 by CanReg5